Restoration of cellular function of mesenchymal stem cells from a hypophosphatasia patient

Gene Therapy

Volumn 17, Issue 4, 2010, Pages 494-502

  Katsube, Y ^a   Kotobuki, N ^a   Tadokoro, M ^a   Kanai, R ^b   Taketani, T ^c   Yamaguchi, S ^b   Ohgushi, H ^a  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^c SHIMANE UNIVERSITY HOSPITAL   (Japan)

Author keywords

Alkaline phosphatase; Cell transplantation; Hypophosphatasia; Mesenchymal stem cells

Indexed keywords

ALKALINE PHOSPHATASE; BONE SIALOPROTEIN; HYDROXYAPATITE; OSTEOCALCIN; OSTEOPONTIN; RETROVIRUS VECTOR;

ADIPOCYTE; ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE DEVELOPMENT; BONE MALFORMATION; BONE MATRIX; BONE MINERALIZATION; CASE REPORT; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINEAGE; CHONDROGENESIS; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE MUTATION; GENETIC TRANSDUCTION; HUMAN; HYPOPHOSPHATEMIA; INFANT; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; PROMOTER REGION; RAT; TISSUE REGENERATION; TREATMENT OUTCOME;

ALKALINE PHOSPHATASE; ANIMALS; BASE SEQUENCE; CELL DIFFERENTIATION; DNA PRIMERS; FEMALE; FLOW CYTOMETRY; GENETIC VECTORS; HUMANS; HYPOPHOSPHATASIA; INFANT; MESENCHYMAL STEM CELLS; MOLECULAR SEQUENCE DATA; OSTEOGENESIS; RATS; RATS, NUDE; RETROVIRIDAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; STEM CELL TRANSPLANTATION; TRANSDUCTION, GENETIC;

RATTUS;

EID: 77950866881     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2009.156     Document Type: Article

References (34)

1. Weiss MJ, Cole DE, Ray K, Whyte MP, Lafferty MA, Mulivor RA et al. A missense mutation in the human liver/bone/kidney alkaline phosphatase gene causing a lethal form of hypophosphatasia. Proc Natl Acad Sci USA 1988; 85: 7666-7669.
2. Zurutuza L, Muller F, Gibrat JF, Taillandier A, Simon-Bouy B, Serre JL et al. Correlations of genotype and phenotype in hypophosphatasia. Hum Mol Genet 1999; 8: 1039-1046.
3. Whyte MP, Walkenhorst DA, Fedde KN, Henthorn PS, Hill CS. Hypophosphatasia: levels of bone alkaline phosphatase immunoreactivity in serum reflect disease severity. J Clin Endocrinol Metab 1996; 81: 2142-2148.
4. Whyte MP, Kurtzberg J, McAlister WH, Mumm S, Podgornik MN, Coburn SP et al. Marrow cell transplantation for infantile hypophosphatasia. J Bone Miner Res 2003; 18: 624-636.
5. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147.
6. Ohgushi H, Caplan AI. Stem cell technology and bioceramics: from cell to gene engineering. J Biomed Mater Res 1999; 48: 913-927.
7. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001; 7: 211-228.
8. De Bari C, Dell'Accio F, Tylzanowski P, Luyten FP. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 2001; 44: 1928-1942.
9. Ikeda E, Hirose M, Kotobuki N, Shimaoka H, Tadokoro M, Maeda M et al. Osteogenic differentiation of human dental papilla mesenchymal cells. Biochem Biophys Res Commun 2006; 342: 1257-1262.
10. Caplan AI, Bruder SP. Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol Med 2001; 7: 259-264.
11. Kotobuki N, Hirose M, Takakura Y, Ohgushi H. Cultured autologous human cells for hard tissue regeneration: preparation and characterization of mesenchymal stem cells from bone marrow. Artif Organs 2004; 28: 33-39.
12. Ohgushi H, Kotobuki N, Funaoka H, Machida H, Hirose M, Tanaka Y et al. Tissue engineered ceramic artificial joint-ex vivo osteogenic differentiation of patient mesenchymal cells on total ankle joints for treatment of osteoarthritis. Biomaterials 2005; 26: 4654-4661.
13. Morishita T, Honoki K, Ohgushi H, Kotobuki N, Matsushima A, Takakura Y. Tissue engineering approach to the treatment of bone tumors: three cases of cultured bone grafts derived from patients' mesenchymal stem cells. Artif Organs 2006; 30: 115-118.
14. Tadokoro M, Kanai R, Taketani T, Uchio Y, Yamaguchi S, Ohgushi H. New bone formation by allogeneic mesenchymal stem cell transplantation in a patient with perinatal hypophosphatasia. J Pediatr 2009; 154: 924-930.
15. Kotobuki N, Katsube Y, Katou Y, Tadokoro M, Hirose M, Ohgushi H. In vivo survival and osteogenic differentiation of allogeneic rat bone marrow mesenchymal stem cells (MSCs). Cell Transplant 2008; 17: 705-712.
16. Hurwitz DR, Kirchgesser M, Merrill W, Galanopoulos T, McGrath CA, Emami S et al. Systemic delivery of human growth hormone or human factor IX in dogs by reintroduced genetically modified autologous bone marrow stromal cells. Hum Gene Ther 1997; 8: 137-156.
17. Dayoub H, Dumont RJ, Li JZ, Dumont AS, Hankins GR, Kallmes DF et al. Human mesenchymal stem cells transduced with recombinant bone morphogenetic protein-9 adenovirus promote osteogenesis in rodents. Tissue Eng 2003; 9: 347-356.
18. Pochampally RR, Horwitz EM, DiGirolamo CM, Stokes DS, Prockop DJ. Correction of a mineralization defect by overexpression of a wild-type cDNA for COL1A1 in marrow stromal cells (MSCs) from a patient with osteogenesis imperfecta: a strategy for rescuing mutations that produce dominant-negative protein defects. Gene Therapy 2005; 12: 1119-1125.
19. Sawai H, Kanazawa N, Tsukahara Y, Koike K, Udagawa H, Koyama K et al. Severe perinatal hypophosphatasia due to homozygous deletion of T at nucleotide 1559 in the tissue nonspecific alkaline phosphatase gene. Prenat Diagn 2003; 23: 743-746.
20. Mornet E, Taillandier A, Peyramaure S, Kaper F, Muller F, Brenner R et al. Identification of fifteen novel mutations in the tissue-nonspecific alkaline phosphatase (TNSALP) gene in European patients with severe hypophosphatasia. Eur J Hum Genet 1998; 6: 308-314.
21. Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, Neel M et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999; 5: 309-313.
22. Horwitz EM, Gordon PL, Koo WK, Marx JC, Neel MD, McNall RY et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci USA 2002; 99: 8932-8937.
23. Cahill RA, Wenkert D, Perlman SA, Steele A, Coburn SP, McAlister WH et al. Infantile hypophosphatasia: transplantation therapy trial using bone fragments and cultured osteoblasts. J Clin Endocrinol Metab 2007; 92: 2923-2930.
24. Caplan AI. Osteogenesis imperfecta, rehabilitation medicine, fundamental research and mesenchymal stem cells. Connect Tissue Res 1995; 31: S9-14.
25. Cai G, Michigami T, Yamamoto T, Yasui N, Satomura K, Yamagata M et al. Analysis of localization of mutated tissuenonspecific alkaline phosphatase proteins associated with neonatal hypophosphatasia using green fluorescent protein chimeras. J Clin Endocrinol Metab 1998; 83: 3936-3942.
26. Nasu M, Ito M, Ishida Y, Numa N, Komaru K, Nomura S et al. Aberrant interchain disulfide bridge of tissue-nonspecific alkaline phosphatase with an Arg433-4Cys substitution associated with severe hypophosphatasia. FEBS J 2006; 273: 5612-5624.
27. Michigami T, Uchihashi T, Suzuki A, Tachikawa K, Nakajima S, Ozono K. Common mutations F310L and T1559del in the tissuenonspecific alkaline phosphatase gene are related to distinct phenotypes in Japanese patients with hypophosphatasia. Eur J Pediatr 2005; 164: 277-282.
28. Wennberg C, Hessle L, Lundberg P, Mauro S, Narisawa S, Lerner UH et al. Functional characterization of osteoblasts and osteoclasts from alkaline phosphatase knockout mice. J Bone Miner Res 2000; 15: 1879-1888.
29. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003; 302: 415-419.
30. Chamberlain JR, Schwarze U, Wang PR, Hirata RK, Hankenson KD, Pace JM et al. Gene targeting in stem cells from individuals with osteogenesis imperfecta. Science 2004; 303: 1198-1201.
31. Surosky RT, Urabe M, Godwin SG, McQuiston SA, Kurtzman GJ, Ozawa K et al. Adeno-associated virus Rep proteins target DNA sequences to a unique locus in the human genome. J Virol 1997; 71: 7951-7959.
32. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861-872.
33. Orimo H, Shimada T. Regulation of the human tissue-nonspecific alkaline phosphatase gene expression by all-transretinoic acid in SaOS-2 osteosarcoma cell line. Bone 2005; 36: 866-876.
34. Matsushima A, Kotobuki N, Tadokoro M, Kawate K, Yajima H, Takakura Y et al. In vivo osteogenic capability of human mesenchymal cells cultured on hydroxyapatite and on beta-tricalcium phosphate. Artif Organs 2009; 33: 474-481.